Article
Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in Japan.
Leukemia research - 1 Dec 2019
Miyamura Takako, Kudo Kazuko, Tabuchi Ken, Ishida Hiroyuki, Tomizawa Daisuke, Adachi Souichi, Goto Hiroaki, Yoshida Nao, Inoue Masami, Koh Katsuyoshi, Sasahara Yoji, Fujita Naoto, Kakuda Harumi, Noguchi Maiko, Hiwatari Mitsuteru, Hashii Yoshiko, Kato Koji, Atsuta Yoshiko, Okamoto Yasuhiro
Abstract excerpt
OBJECTIVE: Pediatric acute myeloid leukemia (AML) with KMT2A rearrangement is detected in 15-20% of all pediatric AML patients and is associated with adverse outcomes even after allogeneic hematopoietic stem cell transplantation (HSCT). To investigate outcomes and prognostic factors, we investigated 90 pediatric AML patients with KMT2A rearrangement after allogeneic HSCT. METHODS: We retrospectively analyzed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
